Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?

PURPOSE: The present study aims to conduct a systematic review of literature reporting on the dose and dosing schedule of dexamethasone (DXM) in relation to clinical outcomes in malignant brain tumor patients, with particular attention to evidence-based practice. METHODS: A systematic search was per...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Neurooncol
Auteurs principaux: Jessurun, Charissa A. C., Hulsbergen, Alexander F. C., Cho, Logan D., Aglio, Linda S., Nandoe Tewarie, Rishi D. S., Broekman, Marike L. D.
Format: Artigo
Langue:Inglês
Publié: Springer US 2019
Sujets:
Topic Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700052/
https://ncbi.nlm.nih.gov/pubmed/31346902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-019-03238-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires